Listen to Dr. Linda-Gail Bekker and Ms. Maureen Luba discuss why an HIV vaccine remains the ultimate game-changer to ending the epidemic and the gaps it will address in the expanding HIV prevention landscape.
Listen to Dr. Susan Buchbinder and Mr. Jontraye Davis discuss what has been learned and built through the past 40 years of HIV vaccine research, including how HIV vaccine scientific advancements and infrastructure were critical to the success of developing a COVID-19 vaccine.
Listen to Swati Gupta, DrPH, MPH, and Marc Dixneuf, PhD, discuss how we can remind key players in policy making of the HIV burden and convince them to invest in HIV vaccine development. This episode also includes special guest commentary by Dr. Jonathan Weber.
Listen to Drs Elizabeth Bukusi, Peter Godfrey-Faussett, and Nina Russell conclude this series by reiterating where we are now after 40 years of research and discussing what might it look like when an HIV vaccine is developed.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.